Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysis
- 397 Downloads
The prognostic value of 18F-deoxyglucose positron emission tomography (18F-FDG PET) on hepatocellular carcinoma (HCC) remains inconclusive. This study aims to investigate the prognostic role of pretreatment 18F-FDG PET on HCC patients by meta-analysis.
PubMed, Embase, Cochrane library, and Wanfang databases were searched until June 2015. Hazard ratios (HRs) with corresponding 95% confidence intervals (CIs) were synthesized by Stata 10.0, and the combined results were used as effective values.
Twenty-two studies containing a total of 1721 patients were identified. According to random-effect model, meta-analysis results showed that high Tumor SUV/Liver SUV (Tsuv/Lsuv) ratio was significantly associated with poorer overall survival (OS) (HR = 2.04; 95% CI 1.50–2.79; P = 0.000) and poorer disease-free survival (HR = 7.17; 95% CI 3.58–14.36; P = 0.000); and high Tumor SUV (Tsuv) value was also correlated with poor OS (HR = 1.53; 95% CI 1.26–1.87; P = 0.000). Meanwhile, subgroup analysis results showed that the significant association above was not altered by study sample size, parameter cutoff value, analytic method, and follow-up period, but there was no significant association between Tsuv/Lsuv ratio and OS in patients who underwent resection (HR = 1.71; 95% CI 1.00–2.92; P = 0.052).
Both high Tsuv/Lsuv ratio and high Tsuv value are associated with poor prognosis in HCC patients. Therefore, pretreatment 18F-FDG PET is a useful tool in predicting the prognosis of HCC patients. More studies with explicit treatment modalities are required to investigate the prognostic value of pretreatment 18F-FDG PET on HCC patients.
KeywordsHepatocellular carcinoma (HCC) 18F-deoxyglucose positron emission tomography (18F-FDG PET) Tumor SUV/Liver SUV (Tsuv/Lsuv) Tumor SUV (Tsuv) Prognosis Meta-analysis
This work was supported by research funding from Jilin Provincial Science & Technology Department (No. 20130413021GH).
Compliance with Ethical Standards
Conflicts of Interest
- 9.Jones M, Hruby G, Solomon M, et al. (2015) Diagnostic Value of <sup> 18 </sup> F-FDG PET/CT in detecting local recurrent colorectal cancer: a pooled analysis of 26 individual studies. Cell Biochem Biophys. [Epub ahead of print]Google Scholar
- 19.Chang ZF, Song P, Wang MQ, et al. (2014) Value of 18F-FDG PET in preoperative TACE of hepatocellular carcinoma. Chin J Oncol 36(5):377–380Google Scholar
- 20.Xu ZQ, Zhang XS, Zhang LQ, et al. (2014) 18F-FDG PET/CT in predicting tumor recurrence for hepatocellular carcinoma after liver transplantation. Chin J Organ Transplant 35(6):341–344Google Scholar
- 26.Kim JW, Seong J, Yun M, et al. (2012) Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 82(3):1172–1178CrossRefPubMedGoogle Scholar